Board Of Directors - Ajanta Pharma Ltd.
Search Company
Registered Address
Registered Office : "Ajanta House", Charkop, Kandivli (West),
Mumbai, Maharashtra - 400067
Tel: 022-66061000
Fax: 022-66061200
Email : info@ajantapharma.com
Website : http://www.ajantapharma.com
Key Officials
Name Designation
Mr. Gaurang C Shah Co. Secretary & Compl. Officer
Mr. Arvind K Agrawal Chief Financial Officer
Listings
BSE , BSE , MCXSX , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Dec 25 Sep 25 Jun 25
Sales 1,206.59 1,220.24 1,208.56
Other Income 25.76 75.03 40.63
Total Expenses 807.75 878.76 828.87
Operating Profit 398.84 341.48 379.69
Interest 1.87 0.73 0.73
Gross Profit 364.84 363.89 369.30
Provisions Made 0.00 0.00 0.00
Depreciation 42.38 41.92 40.31
Taxation 77.42 72.44 74.02
Net Profit / Loss 245.04 249.53 254.97
Equity Capital 25.07 25.07 25.07
Balance Sheet
Mar 25 Mar 24 Mar 23
Share Capital 25.07 25.27 25.27
Reserve & Surplus 3,600.24 3,382.65 3,220.84
Revaluation Reserve 0.00 0.00 0.00
Networth 3,625.31 3,413.57 3,246.45
Total debt - - -
Total Liability 3,625.31 3,413.57 3,246.45
Net Block 1,741.96 1,464.89 1,484.01
Capital work in progress 176.27 256.45 209.47
Investment 481.84 367.14 553.26
Net current asset 1,225.24 1,325.09 999.71
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 3,625.31 3,413.57 3,246.45
Income Statement
  Mar25 Mar24 Mar23
Sales 4,322.04 3,971.12 3,411.27
Other Income 119.87 116.48 132.75
Total Expenses 3,117.32 2,851.69 2,711.99
Operating Profit 1,204.72 1,119.43 699.28
Interest 4.60 6.80 5.23
Adjusted PBDIT 1,324.59 1,235.91 832.03
Depreciation 139.93 132.16 126.95
Adjusted PBT 1,180.06 1,096.95 699.85
Taxation 263.17 289.71 141.13
Net Profit / Loss 916.89 807.24 558.72
Key Ratios
  Mar25 Mar24 Mar23
OPM (%) 27.87 28.18 20.49
GPM (%) 24.63 24.86 16.77
NPM (%) 21.21 20.32 16.37
Earning Retention Ratio 61.86 20.45 83.95
Return on networth (%) 25.29 23.68 17.21
EPS (Rs.) 73.40 64.11 44.37
Dividend payout Ratio 38.14 79.55 16.05
Longterm Debt-Equity Ratio 0.00 0.00 0.00
Current Ratio 2.32 2.65 1.94
Fixed Asset Turnover Ratio 1.23 1.19 1.06
Inventory 1.19 1.17 1.05
Interest coverage Ratio 287.95 181.75 159.09
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 2,825.00 2,827.60
Last Traded Date 16/04/2026 16/04/2026
Last Traded Time 04:01:00 PM 03:58:52 PM
Change (%) -2.19% -1.93%
Day's Open (Rs.) 2,886.35 2,928.70
Previous Close (Rs.) 2,888.15 2,883.20
Day's High (Rs.) 2,898.15 2,928.70
Day's Low (Rs.) 2,814.75 2,811.00
Volume (Rs. In Lacs) 94.04 2494.99
Bid Price (Rs.) 0.00 2,827.60
Bid Quantity 1551
Offer Price (Rs.) 0.00 0.00
Offer Quantity
Exchange Code 532331 AJANTPHARMEQ
Exchange Group A OtherEQ
Board Meetings
Date Purpose
30/01/2026 Quarterly Results
03/11/2025 Quarterly Results & Interim Dividend
28/07/2025 Quarterly Results & Others
Corporate News
Ajanta Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
Ajanta Pharma - Disclosure under SEBI Takeover Regulations
Ajanta Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Ajanta Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Ajanta Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Share Holding Pattern as on 31/03/2026
Major Holder No. of Shares Percentage (%)
Promoters 82,763,777 66.25
Institutional Investors 33,270,791 26.63
Other Investors 973,533 0.78
General Public 7,927,523 6.35